Universe Pharmaceuticals (UPC) Competitors $3.99 +0.10 (+2.57%) As of 01:21 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock UPC vs. REVB, SRNE, ATXI, BIOR, VIRX, BPTSY, HEPA, MYMD, KRBP, and VRPXShould you be buying Universe Pharmaceuticals stock or one of its competitors? The main competitors of Universe Pharmaceuticals include Revelation Biosciences (REVB), Sorrento Therapeutics (SRNE), Avenue Therapeutics (ATXI), Biora Therapeutics (BIOR), Viracta Therapeutics (VIRX), Biophytis (BPTSY), Hepion Pharmaceuticals (HEPA), MyMD Pharmaceuticals (MYMD), Kiromic BioPharma (KRBP), and Virpax Pharmaceuticals (VRPX). These companies are all part of the "pharmaceutical products" industry. Universe Pharmaceuticals vs. Its Competitors Revelation Biosciences Sorrento Therapeutics Avenue Therapeutics Biora Therapeutics Viracta Therapeutics Biophytis Hepion Pharmaceuticals MyMD Pharmaceuticals Kiromic BioPharma Virpax Pharmaceuticals Revelation Biosciences (NASDAQ:REVB) and Universe Pharmaceuticals (NYSE:UPC) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, community ranking, risk, valuation, profitability, dividends, analyst recommendations, media sentiment and institutional ownership. Which has more volatility & risk, REVB or UPC? Revelation Biosciences has a beta of -0.09, meaning that its share price is 109% less volatile than the S&P 500. Comparatively, Universe Pharmaceuticals has a beta of 1.51, meaning that its share price is 51% more volatile than the S&P 500. Which has preferable valuation and earnings, REVB or UPC? Revelation Biosciences has higher earnings, but lower revenue than Universe Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRevelation BiosciencesN/AN/A-$120K-$102.61-0.01Universe Pharmaceuticals$23.02M0.01-$6.16MN/AN/A Do institutionals & insiders hold more shares of REVB or UPC? 12.8% of Revelation Biosciences shares are owned by institutional investors. Comparatively, 0.2% of Universe Pharmaceuticals shares are owned by institutional investors. 0.1% of Revelation Biosciences shares are owned by insiders. Comparatively, 57.4% of Universe Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Does the media refer more to REVB or UPC? In the previous week, Revelation Biosciences had 6 more articles in the media than Universe Pharmaceuticals. MarketBeat recorded 6 mentions for Revelation Biosciences and 0 mentions for Universe Pharmaceuticals. Universe Pharmaceuticals' average media sentiment score of 0.00 beat Revelation Biosciences' score of -0.55 indicating that Universe Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment Revelation Biosciences Negative Universe Pharmaceuticals Neutral Is REVB or UPC more profitable? Universe Pharmaceuticals' return on equity of 0.00% beat Revelation Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Revelation BiosciencesN/A -193.51% -84.00% Universe Pharmaceuticals N/A N/A N/A Does the MarketBeat Community believe in REVB or UPC? Revelation Biosciences received 30 more outperform votes than Universe Pharmaceuticals when rated by MarketBeat users. CompanyUnderperformOutperformRevelation BiosciencesOutperform Votes3062.50% Underperform Votes1837.50% Universe PharmaceuticalsN/AN/A SummaryUniverse Pharmaceuticals beats Revelation Biosciences on 6 of the 10 factors compared between the two stocks. Get Universe Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for UPC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding UPC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UPC vs. The Competition Export to ExcelMetricUniverse PharmaceuticalsPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$172K$6.92B$5.61B$19.79BDividend YieldN/A2.54%5.28%3.82%P/E RatioN/A8.6327.2235.35Price / Sales0.01265.57411.3143.77Price / CashN/A65.8538.3217.51Price / Book0.026.587.014.82Net Income-$6.16M$143.75M$3.23B$1.02B7 Day Performance-6.99%1.52%-0.06%0.38%1 Month Performance-22.07%12.43%8.75%1.79%1 Year Performance-99.72%3.67%32.44%10.03% Universe Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UPCUniverse PharmaceuticalsN/A$3.99+2.6%N/A-99.7%$172K$23.02M0.00220Gap UpREVBRevelation Biosciences0.4476 of 5 stars$0.82-3.2%N/A-97.8%$819KN/A0.0010Short Interest ↑High Trading VolumeSRNESorrento Therapeutics0.3438 of 5 stars$0.00-23.5%N/A-83.8%$717K$60.32M0.00800Gap DownATXIAvenue Therapeutics1.8383 of 5 stars$0.25+14.7%N/A-91.9%$694KN/A0.014Gap DownBIORBiora Therapeutics1.7736 of 5 stars$0.14-1.4%$23.00+16,328.6%-98.1%$633K$892K-0.01120Gap UpVIRXViracta Therapeutics1.9967 of 5 stars$0.02-15.8%$1.75+11,263.6%-97.4%$612KN/A-0.0120Gap DownBPTSYBiophytisN/A$1.73flatN/A-82.2%$607KN/A0.0030Short Interest ↑Gap DownHEPAHepion Pharmaceuticals1.2621 of 5 stars$0.04-27.0%N/A-99.9%$441KN/A-0.0120Short Interest ↓MYMDMyMD PharmaceuticalsN/A$0.16-3.1%N/A-91.4%$380KN/A0.006Gap DownHigh Trading VolumeKRBPKiromic BioPharmaN/AN/AN/AN/A$330KN/A-0.0660Gap DownHigh Trading VolumeVRPXVirpax Pharmaceuticals1.5384 of 5 stars$0.25-0.2%$75.00+30,512.2%-98.7%$304KN/A0.007 Related Companies and Tools Related Companies REVB Alternatives SRNE Alternatives ATXI Alternatives BIOR Alternatives VIRX Alternatives BPTSY Alternatives HEPA Alternatives MYMD Alternatives KRBP Alternatives VRPX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:UPC) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredBanks aren’t ready for this altcoin—are you?Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Universe Pharmaceuticals INC Please log in to your account or sign up in order to add this asset to your watchlist. Share Universe Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy UPC Stock Free UPC Stock Alerts